back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2019-10-31 21:26 Tx date 2019-10-28 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfiel, David
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+300,000 vol |
300,000 | |
| Filed 2019-10-31 21:25 Tx date 2019-06-17 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfiel, David
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-16 23:42 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfiel, David
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$75,000
+500,000 vol $0.15 each |
500,000 | |
| Filed 2019-08-16 23:40 Tx date 2019-06-17 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfiel, David
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-08-16 23:37 Tx date 2019-08-14 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfiel, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
| Filed 2019-08-16 23:36 Tx date 2019-06-17 |
$AVCR
Avricore Health Inc. (formerly Vanc Pharmaceuticals Inc.) |
Farnfiel, David
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|